Valuation: Aptahem AB

Market Cap 90.51L 9L 8L 8L 7L 12.81L 8.48Cr 13.26L 35.89L 4.53Cr 33.73L 33.02L 14Cr P/E 2024
-2.07x
P/E 2025 -3.7x
Enterprise Value 60.87L 6L 5L 5L 5L 9L 5.7Cr 9L 24.13L 3.04Cr 22.69L 22.2L 9.66Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
85.52%
Yield 2024 *
-
Yield 2025 -
1 day+8.39%
3 months-38.77%
6 months-52.45%
Current year-69.52%
Current year 0.28
Extreme 0.277
1.34
1 year 0.28
Extreme 0.277
1.95
3 years 0.28
Extreme 0.277
28
5 years 0.28
Extreme 0.277
87.9
10 years 0.28
Extreme 0.277
1,005
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 01/03/2016
Chief Executive Officer 60 01/01/2014
Director of Finance/CFO 62 -
Director TitleAgeSince
Director/Board Member 60 01/01/2014
Director/Board Member - -
Director/Board Member 74 01/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+8.39%-.--%-65.45%-98.41% 9L
-1.29%-1.76%+51.98%+64.66% 6.63TCr
-0.09%+2.79%+10.75%+95.02% 6.06TCr
+0.63%+1.64%+24.25%+89.70% 5.55TCr
-0.22%-0.33%+10.44%+119.88% 4.76TCr
-0.46%-5.34%+22.13%+28.89% 4.37TCr
-1.95%-15.56%+144.43%+695.29% 3.73TCr
+0.23%+1.66%+14.85%+49.06% 3.66TCr
+2.35%-3.61%+78.64%+60.70% 3.22TCr
+2.01%+6.68%-37.25%+406.79% 2.66TCr
Average +0.98%+0.44%+25.48%+151.16% 4TCr
Weighted average by Cap. -0.03%+0.33%+35.38%+153.72%

Financials

2024 2025
Net sales - -
Net income -85.68L -9L -8L -7L -6L -12.13L -8.02Cr -12.56L -33.98L -4.29Cr -31.94L -31.26L -14Cr -64.9L -6L -6L -5L -5L -9L -6.08Cr -10L -25.74L -3.25Cr -24.19L -23.68L -10Cr
Net Debt -41.32L -4L -4L -3L -3L -6L -3.87Cr -6L -16.39L -2.07Cr -15.4L -15.07L -6.56Cr -29.64L -3L -3L -2L -2L -4L -2.78Cr -4L -11.75L -1.48Cr -11.05L -10.81L -4.71Cr
Projected Income Statement - Annual - Aptahem AB
Logo Aptahem AB
Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.
Employees
3
  1. Stock Market
  2. Stocks
  3. APTA Stock